Skip to main content
SoftOx Solutions AS logo

SoftOx Solutions AS — Investor Relations & Filings

Ticker · SOFTX ISIN · NO0010811961 LEI · 549300AETMWJS91G4A50 OL Manufacturing
Open in API
Filings indexed 572 across all filing types
Latest filing 2024-08-23 Report Publication Anno…
Country NO Norway
Listing OL SOFTX

About SoftOx Solutions AS

https://soft-ox.com/

SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.

Recent filings

Filing Released Lang Actions
SoftOx Solutions AS: Expiry of the subscription period for the Rights Issue today
Report Publication Announcement Classification · 99% confidence The document is a short announcement from SoftOx Solutions AS regarding the expiry of the subscription period for a Rights Issue. It references a Prospectus dated August 5, 2024, and details the deadline for using subscription rights. This type of announcement, which relates to a specific corporate action involving the issuance of new shares (a Rights Issue), falls under the category of Capital/Financing Update (CAP). It is not the full prospectus or a general regulatory filing, but a specific update on a financing event.
2024-08-23 English
SoftOx Solutions AS: Last day of trading in subscription rights
Share Issue/Capital Change Classification · 99% confidence The document is a short announcement regarding the last day of trading for subscription rights related to a Rights Issue. It explicitly mentions the expiration of trading in subscription rights and refers to an earlier Prospectus. Since the document is short (3327 characters) and serves primarily to announce a specific corporate action related to capital structure (Rights Issue/subscription rights), it fits best under Capital/Financing Update (CAP). It is not a full report, an earnings release, or a general regulatory filing (RNS), but a specific update on a financing activity.
2024-08-19 English
SoftOx Solutions AS: Presentation deck and link to today's presentation
Investor Presentation Classification · 98% confidence The document is explicitly titled 'SoftOx Solutions AS Company Presentation' and contains slides detailing company strategy, management structure, investment case, clinical focus (VAP), project plans, and toxicology data summaries. The content is designed to inform potential investors about the company's status and future prospects. This format strongly aligns with an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a short announcement of a report (RPA/RNS).
2024-08-15 English
SoftOx Solutions AS: Presentation deck and link to today's presentation
Report Publication Announcement Classification · 98% confidence The document is extremely short (452 characters) and explicitly states that an 'investor presentation' is attached and provides a link to the recorded presentation. This structure—announcing the availability of presentation materials rather than being the presentation itself—fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the release or publication of company reports/materials. It is not the detailed Investor Presentation (IP) itself, but the announcement of it.
2024-08-15 English
SoftOx Solutions AS: Reminder - Market Update in connection with ongoing Right Issue on Investorweb.no Thursday the 15th of August 2 pm
Regulatory Filings Classification · 99% confidence The document is a short announcement (1281 characters) reminding investors about an upcoming 'Market Update' presentation related to an 'ongoing rights issue'. It specifies the date, time, and location (Investorweb.no) for the presentation, which will focus on the new team and the clinical development program. Since this is an announcement about an upcoming presentation/event rather than the presentation material itself, and it relates to capital raising (Rights Issue), it fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS) if CAP is too specific for an announcement of a presentation. However, given the explicit mention of the 'ongoing Right Issue', CAP is the most relevant category describing the underlying corporate action being discussed. It is not the full report (10-K, IR), nor is it the transcript (CT) or the presentation slides (IP). It is an announcement about an event tied to financing.
2024-08-14 English
SoftOx Solutions AS: Market Update in connection with ongoing Right Issue on Investorweb.no Thursday the 15th of August 2 pm
Capital/Financing Update Classification · 95% confidence The document is a short announcement (986 characters) stating that the company, SoftOx Solutions AS, will provide a 'Market Update' presentation regarding an ongoing 'Right Issue' and upcoming clinical development plans (VAP). It explicitly provides a link to an investor channel where the presentation will be held and recorded. This structure—announcing an upcoming presentation/event rather than containing the full presentation or detailed financial results—strongly suggests it is an announcement about a future investor event. Given the context of a presentation about strategy, team changes, and development programs aimed at investors, the most fitting category is Investor Presentation (IP). However, since the document itself is merely an announcement *of* the presentation, and not the presentation content itself, it aligns better with the 'Report Publication Announcement' (RPA) or a general Regulatory Filing (RNS) if RPA is too specific. Since the content is about an upcoming investor-focused presentation, RPA is a strong candidate, but IP covers the *subject matter* of the event. Given the 'MENU VS MEAL' rule, if this were the actual presentation slides, it would be IP. As it is just the notice of the event, RPA (Report Publication Announcement) is appropriate, as it announces the publication/event. However, since the event is explicitly an investor presentation, and the content focuses on strategy/team/development, IP is also highly relevant. I will lean towards IP as the subject matter is clearly an investor presentation, even if this specific text is the invitation/notice, as it is more descriptive than a generic RPA.
2024-08-12 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.